March 28, 2025 | #MedscapeEducation #AICardiology
Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and outcomes.

One of the key areas where AI is making a significant impact is in the early detection of cardiovascular diseases (CVD). Traditional methods often fail to diagnose CVD before symptoms appear, leading to delayed treatment and poorer outcomes. AI, however, can analyse vast amounts of data from electrocardiograms (ECGs) and other diagnostic tools to identify early signs of heart disease that might be missed by human eyes, which improves diagnostic accuracy and patient outcomes.1
AI also plays a crucial role in personalising treatment plans. By analysing patient data, AI can help doctors tailor treatments to individual needs, ensuring that each patient receives the most effective therapy. This personalised approach is particularly beneficial in managing complex conditions like heart failure, where treatment needs to be adjusted frequently based on the patient’s response.
The use of wearable and portable devices is another exciting development in AI cardiology. These devices, such as smartwatches and portable ECG monitors, enable continuous monitoring of heart health, providing real-time data to both patients and healthcare providers. This continuous monitoring can lead to early intervention and better management of chronic conditions, ultimately reducing hospitalisations and improving quality of life.2
Despite these advancements, there are still significant challenges to overcome when it comes to getting healthcare professionals confident about realising the full potential of these AI-powered technologies and tools. Healthcare professionals already face an exponential rise in medical information which is doubling at least every 73 days.3 Furthermore, the integration of AI into healthcare systems requires robust data privacy measures and regulatory oversight to ensure patient safety and data security.4
AI is poised to transform cardiology by enhancing early disease detection, personalising treatment and improving overall care quality. As technology continues to evolve, the potential for AI to improve outcomes for patients with cardiovascular disorders is immense; however, ongoing education is needed in its widespread adoption to ensure it is being utilised to its full capabilities. The future of cardiology is bright, with AI leading the way towards more efficient, accurate and personalised care.
If you want to learn more about how Medscape Education is improving outcomes in cardiology through education, contact Ellen Jenner
[1] Attia, Z.I., et al. (2019). ‘An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction’, The Lancet, 394(10201), pp. 861–867. doi: 10.1016/S0140-6736(19)31721-07.
[2] Khunte, A., et al. (2023). ‘Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices’, NPJ Digital Medicine, 6(1), p. 124. doi: 10.1038/s41746-023-00869-w.
[3] Koenig, H.G. (2012) ‘Religion, spirituality, and health: The research and clinical implications’, International Scholarly Research Notices, 2012, pp. 1–33. doi: 10.5402/2012/278730.
[4] Chustecki M. Interact J Med Res. 2024;13:e53616; Davenport T, et al. Future Healthc J. 2019;6:94-98; Khera R, et al. J Am Coll Cardiol. 2024;84:97-114; Khera R, et al. JAMA. 2023;330:2255-2257.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...
Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
